Latest Amgen Stories
FIND FH Initiative Unites Industry, Advocacy Community and Academia in an Effort to Support People Affected by Familial Hypercholesterolemia (FH), a Serious Genetic Disorder THOUSAND OAKS,
US Submission Designed to Support Conversion From Accelerated to Full FDA Approval and Expansion of Current Approved Indication THOUSAND OAKS, Calif.
THOUSAND OAKS, Calif., Jan. 22, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2014 financial results on Tuesday, Jan.
-- First biosimilar from Samsung Bioepis to advance to EMA regulatory review -- INCHEON, South Korea, Jan.
Exploratory Analysis of Phase 2 Trial Shows Earlier and Sustained Responses in Patients Treated With Vectibix Versus Bevacizumab THOUSAND OAKS, Calif., Jan.
PORTLAND, Oregon, January 15, 2015 /PRNewswire/ -- A new report by Allied Market Research titled, "Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography)
MD Anderson's Moon Shots Program key to Collaboration THOUSAND OAKS, Calif. and HOUSTON, Jan.
LAKE FOREST, Ill., Jan.
THOUSAND OAKS, Calif., Jan. 8, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 33(rd) Annual J.P. Morgan Healthcare Conference at 9:30 a.m. PT on Tuesday, Jan.
Alliance Combines Amgen's Oncology Targets and Kite's Leading CAR T Cell Therapy Platform to Develop new Therapeutic Candidates THOUSAND OAKS, Calif.
- A person in a secondary role, specifically the second most important character (after the protagonist).